Possible Commonalities of Clinical Manifestations Between Dystonia and Catatonia

Ishizuka, Kanako; Tachibana, Masakatsu; Inada, Takao

doi:10.3389/fpsyt.2022.876678

Cited by 4 publications

(2 citation statements)

References 18 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… Source: Arnts et al (2020), Cuevas-Esteban et al (2022), Denysenko et al (2018), Harten et al (1999), Ishizuka et al (2022), Morrison (2006), Oldham and Lee (2015), Rasmussen et al (2016), Taylor and Fink (2003), Wang and Rehman (2021), Wong (2010). NCSE: non-convulsive status epilepticus; NMS: neuroleptic malignant syndrome; SS: serotonin syndrome. …”

Section: Clinical Assessmentmentioning

confidence: 99%

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

et al. 2023

View full text Add to dashboard Cite

The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.

show abstract

Section: Clinical Assessmentmentioning

confidence: 99%

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Dystonia can be mild or severe and be accompanied by other symptoms, such as difficulty speaking or swallowing [ 30 ]. The abnormal postures in patients with dystonia may be misdiagnosed as functional, since dystonia often occurs in patients with neuropsychiatric diseases, and it can be mistakenly identified as catatonia [ 31 , 32 ]. In most cases, acute dystonia is a self-limited condition that resolves within a few days or weeks [ 33 ].…”

Section: Dystoniamentioning

confidence: 99%

Overview of Movement Disorders Secondary to Drugs

Rissardo,

Vora,

Mathew

et al. 2023

Clinics and Practice

View full text Add to dashboard Cite

Drug-induced movement disorders affect a significant percentage of individuals, and they are commonly overlooked and underdiagnosed in clinical practice. Many comorbidities can affect these individuals, making the diagnosis even more challenging. Several variables, including genetics, environmental factors, and aging, can play a role in the pathophysiology of these conditions. The Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Statistical Classification of Diseases and Related Health Problems (ICD) are the most commonly used classification systems in categorizing drug-induced movement disorders. This literature review aims to describe the abnormal movements associated with some medications and illicit drugs. Myoclonus is probably the most poorly described movement disorder, in which most of the reports do not describe electrodiagnostic studies. Therefore, the information available is insufficient for the diagnosis of the neuroanatomical source of myoclonus. Drug-induced parkinsonism is rarely adequately evaluated but should be assessed with radiotracers when these techniques are available. Tardive dyskinesias and dyskinesias encompass various abnormal movements, including chorea, athetosis, and ballism. Some authors include a temporal relationship to define tardive syndromes for other movement disorders, such as dystonia, tremor, and ataxia. Antiseizure medications and antipsychotics are among the most thoroughly described drug classes associated with movement disorders.

show abstract

Expanding the phenotype of NEDAMSS with a psychiatric perspective: analysis of a new case, and a systematic review of the literature

Kristiansen,

Vernal,

Hulgaard

2024

Eur Child Adolesc Psychiatry

View full text Add to dashboard Cite

Possible Commonalities of Clinical Manifestations Between Dystonia and Catatonia

Cited by 4 publications

References 18 publications

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

Overview of Movement Disorders Secondary to Drugs

Expanding the phenotype of NEDAMSS with a psychiatric perspective: analysis of a new case, and a systematic review of the literature

Contact Info

Product

Resources

About